Valentina Zammit
Palermo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study.
Journal: Hematological oncology
Published: October 18, 2025
BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors.
Journal: Frontiers in oncology
Published: April 03, 2019
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.
Journal: International journal of molecular sciences
Published: March 23, 2019
Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report.
Journal: Oncology letters
Published: January 29, 2019
Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma.
Journal: Leukemia & lymphoma
Published: June 03, 2017
Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study.
Journal: Leukemia research
Published: April 04, 2017
Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
Journal: American journal of hematology
Published: November 28, 2011
Last Updated: 09/26/2026